Actualités et vidéos - LUMINEX CORP.

VANCOUVER, British Columbia, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Luminex Resources Corp. (TSXV: LR) (US OTC: LUMIF) (the “Company” or “Luminex”) is pleased to announce that it has finalized the layout of an exploratory 4,500 metre diamond drilling program at its Orquideas earn-in project with First Quantum Minerals, located in the province of Zamora-Chinchipe in southeast Ecuador. The Company has applied for drilling and water permits and drilling operations should commence following...

Luminex Corporation Reports Third Quarter 2018 Financial Results PR Newswire AUSTIN, Texas, Nov. 5, 2018 AUSTIN, Texas , Nov. 5, 2018 /PRNewswire/ -- Luminex Corporation (Nasdaq: LMNX) today announced financial results for the third quarter of 2018. Financial and operating highlights for the quarter include: Third quarter 2018 consolidated revenue was $72.4 million , a decrease of 2% compared to the third quarter 2017. Revenue growth, excluding LabCorp sales, was up 7% over the prior year...

Luminex Corporation to Acquire MilliporeSigma's Flow Cytometry Portfolio PR Newswire AUSTIN, Texas, Oct. 22, 2018 - Strategic Deal Extends and Diversifies Company's Footprint in Life Science Research - Expands Luminex's Flow-based Instrument Offering Into Cellular Analysis with Acquisition of Amnis and Guava Branded Instruments - Transaction Expected to Close by End of 2018 AUSTIN, Texas , Oct. 22 , 2018 /PRNewswire/ -- On October 18 , Luminex Corporation (NASDAQ: LMNX ) announced that the...

Merck anuncia acuerdo para venderle a Luminex Corporation los negocios de las tecnologías Amnis® y Guava® para citometría de flujo PR Newswire DARMSTADT, Alemania, 18 de octubre de 2018 - Todos los reactivos asociados de estas marcas se incluyen en el acuerdo - Acuerdo estratégico le permite a Luminex aumentar su presencia en el multimillonario mercado de la citometría de flujo - Se tiene previsto cerrar el acuerdo a finales de 2018 DARMSTADT, Alemania, 18 de octubre de 2018 /PRNewswire/...

Merck annonce un accord de vente de ses activités de technologies de cytométrie en flux Amnis® et Guava® à Luminex Corporation PR Newswire DARMSTADT, Allemagne, 18 octobre 2018 - Tous les réactifs associés sous ces marques sont inclus dans l'accord - Cet accord stratégique permet à Luminex d'accroître sa présence sur le marché de la cytométrie en flux qui représente plusieurs milliards de dollars - La transaction devrait être conclue fin 2018 DARMSTADT, Allemagne, 18 octobre 2018...

Acuerdo de venta de las unidades de Citometría de flujo Amnis® y Guava® Technologies de Merck a Luminex Corporation PR Newswire DARMSTADT, Alemania, 18 de octubre de 2018 - En el acuerdo se incluyen todos los reactivos asociados con estas marcas. - El acuerdo estratégico permite a Luminex aumentar su presencia en el mercado de citometría de miles de millones de dólares - Se espera que el acuerdo se cierre a finales de 2018. DARMSTADT, Alemania, 18 de octubre de 2018 /PRNewswire/ -- Merck ,...

Merck Announces Agreement to Sell Amnis(R) Flow Cytometry and Guava(R) Technologies Businesses to Luminex Corporation - All associated reagents under these brands included in the deal- Strategic agreement allows Luminex to increase footprint in multi-billion-dollar flow cytometry market- Deal expected to close at end of 2018 PR Newswire DARMSTADT, Germany, Oct. 18, 2018 DARMSTADT, Germany , Oct. 18, 2018 /PRNewswire/ -- Merck , the vibrant science and technology company, today announced the...

Merck Announces Agreement to Sell Amnis® Flow Cytometry and Guava® Technologies Businesses to Luminex Corporation PR Newswire DARMSTADT, Germany, Oct. 18, 2018 - All associated reagents under these brands included in the deal - Strategic agreement allows Luminex to increase footprint in multi-billion-dollar flow cytometry market - Deal expected to close at end of 2018 DARMSTADT, Germany , Oct. 18, 2018 /PRNewswire/ -- Merck , the vibrant science and technology company, today announced the...

Merck verkauft Amnis® Flow Cytometry und Guava® Technologies an Luminex Corporation PR Newswire DARMSTADT, Deutschland, 18 Oktober 2018 - Alle zugehörigen Reagenzien dieser Marken werden von Luminex übernommen - Strategische Vereinbarung ermöglicht es Luminex, die Präsenz im Multi-Milliarden-Dollar-Markt für Durchflusszytometrie zu erhöhen - Transaktion voraussichtlich Ende 2018 abgeschlossen DARMSTADT, Deutschland, 18 Oktober 2018 /PRNewswire/ -- Merck , ein führendes Wissenschafts-...

Luminex Corporation to Acquire MilliporeSigma's Flow Cytometry Portfolio - Strategic Deal Extends and Diversifies Company's Footprint in Life Science Research - Expands Luminex's Flow-based Instrument Offering Into Cellular Analysis with Acquisition of Amnis and Guava Branded Instruments - Transaction Expected to Close by End of 2018 PR Newswire AUSTIN, Texas, Oct. 18, 2018 AUSTIN, Texas , Oct. 18, 2018 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that the company has...

Luminex Corporation Third Quarter Earnings Release Scheduled for November 5, 2018 PR Newswire AUSTIN, Texas, Oct. 15, 2018 AUSTIN, Texas , Oct. 15, 2018 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that it expects to report results for the third quarter ended September 30, 2018 on Monday, November 5, 2018 . A press release announcing the results is scheduled for release after the close of trading on that date. Management will hold a conference call to discuss the operating...

VANCOUVER, British Columbia, Oct. 05, 2018 (GLOBE NEWSWIRE) -- Luminex Resources Corp. (TSXV: LR) (the “Company” or “Luminex”) announces that it has granted incentive stock options under the Company's stock option plan to certain directors, officers, employees and consultants of the Company to purchase up to an aggregate of 1,200,000 common shares in the capital stock of the Company. The options are exercisable at a price of $0.80 per share, will expire on October 5, 2023, and will vest...

VANCOUVER, British Columbia, Sept. 24, 2018 (GLOBE NEWSWIRE) -- Luminex Resources Corp. (TSXV: LR) (the “Company” or “Luminex”) is pleased to announce the signing of a formal earn-in and joint venture agreement (the “Earn-In Agreement”) with a subsidiary of the Anglo American plc group (“Anglo American”) relating to Pegasus A, Pegasus B and Luz concessions in Ecuador (the “Properties”). Anglo American has the right to earn a 60% ownership interest in a joint venture company...

Luminex Corporation Declares Third Quarter Cash Dividend PR Newswire AUSTIN, Texas, Sept. 11, 2018 AUSTIN, Texas , Sept. 11, 2018 /PRNewswire/ -- Luminex Corporation (Nasdaq:LMNX) (the "Company"), today announced that its board of directors declared a cash dividend for the third quarter of 2018 of $0.06 per share of common stock payable on October 12 , 2018 to stockholders of record as of the close of business September 21, 2018 . About Luminex Corporation At Luminex, our mission is to empower...

VANCOUVER, British Columbia, Aug. 31, 2018 (GLOBE NEWSWIRE) -- Ross J. Beaty, of 1550 – 625 Howe Street, Vancouver, British Columbia, V6C 2T6, today announced that on August 31, 2018 he acquired ownership of 6,455,125 common shares (the “ Common Shares ”) of Luminex Resources Corp. (“ Luminex ”) and 131,250 stock options of Luminex (“ Options ”), pursuant to a plan of arrangement, whereby Lumina Gold Corp. (“ Lumina ”) spun out certain of its assets to its existing shareholders...

Luminex Corporation Reports Second Quarter 2018 Financial Results PR Newswire AUSTIN, Texas, Aug. 6, 2018 AUSTIN, Texas , Aug. 6, 2018 /PRNewswire/ -- Luminex Corporation (Nasdaq:LMNX) today announced financial results for the second quarter of 2018. Financial and operating highlights for the quarter include: Second quarter 2018 consolidated revenue was $79.6 million , an increase of 4% compared to the second quarter 2017. Second quarter 2018 GAAP net income was $5.7 million , an increase of 2%...

Luminex Corporation Second Quarter Earnings Release Scheduled for August 6, 2018 PR Newswire AUSTIN, Texas, July 13, 2018 AUSTIN, Texas , July 13, 2018 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that it expects to report results for the second quarter ended June 30, 2018 on Monday, August 6, 2018 . A press release announcing the results is scheduled for release after the close of trading on that date. Management will hold a conference call to discuss the operating...

BOSTON, June 19, 2018 (GLOBE NEWSWIRE) -- Luminex Trading & Analytics LLC, a buy side-owned trading venue delivering efficient, low-cost block executions, today announced that May 2018 was its most successful month to date, as measured by total shares traded within the venue. In addition, in the month of April 2018, Luminex was again among the leaders in the alternative trading system (ATS) industry1 for average trade size across all three block trading categories that FINRA (Financial Industry...

Luminex Initiates Clinical Trials for VERIGENE® II Gastrointestinal Assay PR Newswire AUSTIN, Texas, June 13, 2018 AUSTIN, Texas , June 13, 2018 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced the company recently began clinical studies for the Gastrointestinal (GI) Assay on the VERIGENE® II System, its new sample to answer benchtop molecular diagnostic system in development. The VERIGENE System enables clinicians to rapidly identify the pathogens responsible for some of the...

Luminex Corporation to Present at Upcoming Healthcare Investor Conferences PR Newswire AUSTIN, Texas, May 18, 2018 AUSTIN, Texas , May 18, 2018 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that Homi Shamir , President and Chief Executive Officer of Luminex will participate in an analyst-led fireside chat at the UBS Global Healthcare Conference to be held May 21, 2018 and will present at the Jefferies 2018 Global Healthcare conference to be held June 5 , 2018. Both...